USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $-5.34 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $0.00 |
Catabasis Pharmaceuticals's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-3.04 | $-3.90 | $-2.45 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-3.04 | $-0.57 | $-0.77 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 9, 2021 | Jun 2021 | $-1.82 | $-5.34 | -193.41% |
| May 13, 2021 | Mar 2021 | $-0.92 | $-45.60 | -4856.52% |
| Mar 11, 2021 | Dec 2020 | $-2.04 | $-2.64 | -29.41% |
| Nov 12, 2020 | Sep 2020 | $-3.06 | $-3.36 | -9.80% |
| Aug 10, 2020 | Jun 2020 | $-2.73 | $-3.18 | -16.48% |
| May 12, 2020 | Mar 2020 | $-2.46 | $-3.00 | -21.95% |
| Mar 10, 2020 | Dec 2019 | $-3.69 | $-3.30 | 10.57% |
| Nov 7, 2019 | Sep 2019 | $-3.82 | $-3.36 | 12.00% |
| Aug 8, 2019 | Jun 2019 | $-3.64 | $-3.72 | -2.22% |
| May 14, 2019 | Mar 2019 | $-4.17 | $-3.72 | 10.79% |
| Mar 14, 2019 | Dec 2018 | $-5.42 | $-5.10 | 5.87% |
| Nov 13, 2018 | Sep 2018 | $-8.09 | $-4.80 | 40.66% |
| Aug 9, 2018 | Jun 2018 | $-15.90 | $-12.00 | 24.53% |
| May 10, 2018 | Mar 2018 | $-13.50 | $-17.40 | -28.89% |
| Mar 15, 2018 | Dec 2017 | $-18.30 | $-14.40 | 21.31% |
| Nov 9, 2017 | Sep 2017 | $-19.60 | $-18.60 | 5.10% |
| Aug 10, 2017 | Jun 2017 | $-23.40 | $-19.20 | 17.95% |
| May 11, 2017 | Mar 2017 | $-27.20 | $-24.60 | 9.56% |
| Mar 16, 2017 | Dec 2016 | $-29.25 | $-28.20 | 3.59% |
| Nov 10, 2016 | Sep 2016 | $-38.80 | $-32.40 | 16.49% |
| Aug 11, 2016 | Jun 2016 | $-6.40 | $-6.10 | 4.69% |
| May 12, 2016 | Mar 2016 | $-6.40 | $-6.10 | 4.69% |
| Mar 2, 2016 | Dec 2015 | $-7.13 | $-6.30 | 11.68% |
| Nov 12, 2015 | Sep 2015 | $-0.64 | $-0.55 | 14.06% |
| Aug 13, 2015 | Jun 2015 | $-0.71 | $-8.07 | -1036.62% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 11, 2021 | Dec 2020 | $-2.01 | $-12.18 | - |
| Mar 10, 2020 | Dec 2019 | $-2.41 | $-14.10 | - |
| Mar 14, 2019 | Dec 2018 | $-4.93 | $-39.30 | - |
| Mar 15, 2018 | Dec 2017 | $-1.37 | $-76.80 | - |
| Mar 16, 2017 | Dec 2016 | - | $-72.80 | - |
| Mar 2, 2016 | Dec 2015 | - | $-14.92 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 9, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 13, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 11, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 10, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 12, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 10, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 7, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 8, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 14, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 14, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 13, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 9, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 10, 2018 | Mar 2018 | $130.00K | $250.00K | 1.92% |
| Mar 15, 2018 | Dec 2017 | $130.00K | $250.00K | 1.92% |
| Nov 9, 2017 | Sep 2017 | - | $250.00K | - |
| Aug 10, 2017 | Jun 2017 | - | $0.00 | - |
| May 11, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 16, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 10, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 11, 2016 | Jun 2016 | - | $0.00 | - |
| May 12, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 2, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 12, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 13, 2015 | Jun 2015 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 11, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 10, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 14, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 15, 2018 | Dec 2017 | $400.00K | $500.00K | 25.00% |
| Mar 16, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 2, 2016 | Dec 2015 | - | $0.00 | - |
CATB's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
Catabasis Pharmaceuticals's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.
Catabasis Pharmaceuticals's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.
CATB's earnings per share (EPS) was $-12.18, missing the consensus analysts forecast of $-2.01 by 505.97% , and higher than the previous year's EPS (Dec 2019) by -13.62%.
Revenues were $0.00.
The company reported a net income of $-37.30M.
Catabasis Pharmaceuticals reported a free cash flow of $-32.52M for its fiscal year, compared to $-26.58M a year ago.
The company ended the fiscal year with $1.05M in total debt, a decrease of -53.57% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
